N-Acetyl SLB is a structurally related impurity derived from Carbamazepine, featuring an acetylated amide functionality at the 5-position of the dibenzazepine core. Its molecular architecture incorporates a 10,11-epoxy bridge and a N-acetyl substituent, distinguishing it from the parent drug by the absence of the terminal methyl group. This compound arises via non-enzymatic acetylation during synthetic processes involving amidation steps. The compound serves as a critical HPLC reference standard for quantifying process-specific impurities in Carbamazepine formulations.
On Request